With Apple expected to ship up to 80 million iPhone XS and XS Max devices in the second half of 2018, DarioHealth hopes to cash in on this and get more people on its platform.
DarioHealth CEO, Erez Raphael, said compatibility with the two new iPhones extended his company’s market reach and “also increases the value of our DarioEngage platform for healthcare providers and employers who are looking for a patient coaching platform that seamlessly integrates with the patient’s mobile phone for real-time data and communication.”
Raphael explained that DarioHealth’s digital health solutions were designed to “improve the health and wellbeing of people living with chronic conditions and the mobile phone is key point of contact, monitoring, and communication with patients.”
DarioHealth believes it’s well on its path to becoming a lifestyle brand for people living with diabetes and not just a glucose monitor. It hopes it can follow the healthcare trends led by FitBit, which is seen as a lifestyle brand rather than just a pedometer. Fitbit, also made the news lately announcing a Blue Cross Blue Shield Fitbit partnership allowing BCBS insured members to buy Fitbits at half the price.
DarioHealth’s Blood Glucose Monitoring System has been cleared in the U.S. and is approved in Europe, Canada, and Australia. The system is commercially available in the U.S., Canada, the United Kingdom, Germany, Italy, the Netherlands, and Australia.
DarioHealth’s app is also compatible with some devices on the Android platform.
The Centers for Disease Control and Prevention estimate that more than 100 million people have diabetes or prediabetes in the U.S. Diabetes was the seventh leading cause of death in the U.S. in 2015.